XORTX Therapeutics Inc.

TSXV:XRTX Stock Report

Market Cap: CA$6.4m

XORTX Therapeutics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for XORTX Therapeutics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth54.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation

Aug 23
Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation

XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business

Apr 01
XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business

We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow

Dec 16
We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow

Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth

Sep 01
Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as XORTX Therapeutics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TSXV:XRTX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2024N/A-1-4-4N/A
3/31/2024N/A-3-5-5N/A
12/31/2023N/A-2-7-7N/A
9/30/2023N/A-7-9-9N/A
6/30/2023N/A-7-9-9N/A
3/31/2023N/A-7-9-9N/A
12/31/2022N/A-8-9-9N/A
9/30/2022N/A1-8-8N/A
6/30/2022N/A-3-8-8N/A
3/31/2022N/A-2-6-6N/A
1/1/2022N/A-2-5-5N/A
9/30/2021N/A-900N/A
6/30/2021N/A-300N/A
3/31/2021N/A-300N/A
12/31/2020N/A-1-1-1N/A
9/30/2020N/A-1-2-2N/A
6/30/2020N/A-1-2-2N/A
3/31/2020N/A0-2-2N/A
12/31/2019N/A000N/A
9/30/2019N/A000N/A
6/30/2019N/A-100N/A
3/31/2019N/A-1-1-1N/A
12/31/2018N/A-3-1-1N/A
9/30/2018N/A-3-1-1N/A
6/30/2018N/A-3-1-1N/A
3/31/2018N/A-3N/A-1N/A
12/31/2017N/A0N/A0N/A
9/30/2017N/A0N/A0N/A
6/30/2017N/A0N/A0N/A
3/31/2017N/A0N/A0N/A
12/31/2016N/A0N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if XRTX's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if XRTX's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if XRTX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if XRTX's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if XRTX's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if XRTX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y